Net Cash Provided by (Used in) Operating Activities |
1.48M |
USD |
+44.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-25K |
USD |
-56.3% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-1.99M |
USD |
+36.4% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
88.8M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-592K |
USD |
+73.7% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
28.3M |
USD |
-11.1% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
46.7M |
USD |
+9.61% |
Dec 31, 2023 |
Q4 2023 |
Payments to Acquire Property, Plant, and Equipment |
1.99M |
USD |
-36.4% |
Mar 31, 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
297M |
USD |
+3.4% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-6.64M |
USD |
-87.3% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-691K |
USD |
+22.8% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
903K |
USD |
-92.5% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
112M |
USD |
+0.71% |
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
-3K |
USD |
+98.8% |
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
4.58M |
USD |
-37% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
18.4M |
USD |
+70.8% |
Dec 31, 2023 |
Q4 2023 |
Share-based Payment Arrangement, Expense |
303K |
USD |
-83% |
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
25K |
USD |
|
Dec 31, 2022 |
Q4 2022 |